New dengue vaccine

Amidst the persistent global threat of dengue fever, a breakthrough has emerged with WHO granting pre-qualification to a new vaccine for the mosquito-borne disease. This significant development marks a pivotal moment in the ongoing battle against dengue virus, offering renewed hope for millions worldwide.

Dengue fever poses a formidable public health challenge in numerous countries across the globe. With its debilitating symptoms ranging from fever and severe joint pain to potentially fatal complications, the disease imposes a heavy burden on affected communities and health systems. WHO’s pre-qualification of the new vaccine signifies a critical step forward in addressing this pressing global health issue. The pre-qualification of the new dengue vaccine holds immense promise for countries grappling with the burden of the disease. By adopting comprehensive mosquito control measures, nations can bolster their efforts to prevent and mitigate dengue outbreaks. Furthermore, equitable access to the new dengue vaccine must be ensured, particularly in resource-limited settings where the burden of the disease is most pronounced.

Pakistan has grappled with recurrent dengue outbreaks in recent years, particularly during the monsoon season when favourable conditions for mosquito breeding prevail. These outbreaks have placed immense strain on the country’s healthcare infrastructure. The availability of a WHO-prequalified dengue vaccine presents Pakistan with a valuable tool that can be incorporated into the national immunisation programme. Targeting vulnerable populations through this will bolster the country’s capacity to prevent and mitigate dengue outbreaks. Ultimately, the effectiveness of the new dengue vaccine in Pakistan will depend on the proactive actions taken by authorities to capitalise on this opportunity.

Published in The Express Tribune, May 19^th, 2024.

Like Opinion & Editorial on Facebook, follow @ETOpEd on Twitter to receive all updates on all our daily pieces.